1,435
Views
9
CrossRef citations to date
0
Altmetric
Review

Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice

, &
Pages 373-383 | Received 20 Jan 2020, Accepted 13 Mar 2020, Published online: 19 Mar 2020

References

  • Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241. .
  • Baldessarini RJ, Tondo L, Hennen J, et al. Treatment delays in bipolar disorders [20] (multiple letters). Am J Psychiatry. 1999;156(5):811–812. .
  • Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284–287. .
  • Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord. 2014;16:22–36.
  • Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.
  • Viguera AC, Tondo L, Koukopoulos AE, et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011;168:1179–1185.
  • Viguera AC. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179–184.
  • Di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry. 2013;70:168–175.
  • Vesga-López O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008;65:805–815.
  • Hirschfeld RMA, Williams JBW, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry. 2000;157:1873–1875.
  • Clark CT, Sit DKY, Driscoll K, et al. Does screening with the MDQ and EPDS improve identification of bipolar disorder in an obstetrical sample? Depress. Anxiety. 2015;32:518–526.
  • Frey BN, Simpson W, Wright L, et al. Sensitivity and specificity of the mood disorder questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period. J Clin Psychiatry. 2012;73:1456–1461.
  • Masters GA, Brenckle L, Sankaran P, et al. Positive screening rates for bipolar disorder in pregnant and postpartum women and associated risk factors. Gen Hosp Psychiatry. 2019;61:53–59.
  • Merrill L, Mittal L, Nicoloro J, et al. Screening for bipolar disorder during pregnancy. Arch Womens Ment Health. 2015;18:579–583.
  • Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70:490–498.
  • Sharma V, Khan M, Corpse C, et al. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord. 2008;10:742–747.
  • Sharma V, Doobay M, Baczynski C. Bipolar postpartum depression : an update and recommendations. J Affect Disord. 2017;219:105–111.
  • Sharma V, Baczynski C. Is bipolar post-partum depression overlooked? Lancet Psychiatry. 2019;6:891–892.
  • Sharma V, Pope CJ. Pregnancy and bipolar disorder: a systematic review. J Clin Psychiatry. 2012;73:1447–1455.
  • Viguera AC, Cohen LS, Bouffard S, et al. Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry. 2002;159:2102–2104.
  • Salim M, Sharma V, Anderson KK. Recurrence of bipolar disorder during pregnancy: a systematic review. Arch Womens Ment Health. 2018;21:475–479.
  • Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164:1817–1824.
  • Newport DJ, Stowe ZN, Viguera AC, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord. 2008;10:432–436.
  • Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189:E747.
  • Veroniki AA, Rios P, Cogo E, et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: A systematic review and network meta-analysis. BMJ Open. 2017;7:1-11.
  • Marengo E, Martino DJ, Igoa A, et al. Unplanned pregnancies and reproductive health among women with bipolar disorder. J Affect Disord. 2015;178:201–205.
  • Patel N, Viguera AC, Baldessarini RJ. Mood-stabilizing anticonvulsants, spina bifida, and folate supplementation. J Clin Psychopharmacol. 2017;1:7-10.
  • Williams J, Ryan D, Thomas-Peter K, et al. Best practice guidelines for mental health disorders in the perinatal period. [Internet]. 2014 [cited 2020 Jan 15]. Available from: http://bookstore.cw.bc.ca.
  • National Institute for Health and Care Excellence. Antenatal and postnatal mental health: Clinical management and service guidance. 2014;1-53.
  • Fornaro M, Maritan E, Ferranti R, et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020;177:76–92.
  • Boden R, Lundgren M, Brandt L, et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ. 2012;345:e7085–e7085.
  • Kim J-H, Choi SS, Ha K. A closer look at depression in mothers who kill their children: is it unipolar or bipolar depression? J.Clin Psychiatry. 2008;69:1625–1631.
  • Wesseloo R, Wierdsma AI, Van Kamp IL, et al. Lithium dosing strategies during pregnancy and the postpartum period. Br J Psychiatry. 2017;211:31–36.
  • Berber MJ. FINISH: remembering the discontinuation syndrome. Flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal (anxiety/agitation). J Clin Psychiatry. 1998;59:255.
  • Hudak R, Wisner KL. Diagnosis and treatment of postpartum obsessions and compulsions that involve infant harm. Am J Psychiatry. 2012;169:360–363.
  • Sharma V. Pharmacotherapy of postpartum obsessive–compulsive disorder: a systematic review. Expert Rev Neurother. 2018;18:925–931.
  • Wesseloo R, Liu X, Clark CT, et al. Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: a population-based cohort study. J Affect Disord. 2017;218:394–397.
  • Clark CT, Klein AM, Perel JM, et al. Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry. 2013;170:1240–1247.
  • Sharma V, Sommerdyk C, Xie B, et al. Pharmacotherapy of bipolar II disorder during and after pregnancy. Curr Drug Saf. 2013;8:246–252.
  • U.S. Food & Drug Administration. Pregnancy, lactation, and reproductive potential: labeling for human prescription drug and biological products-content and format | FDA. [Internet]. [ cited 2020 Jan 15]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pregnancy-lactation-and-reproductive-potential-labeling-human-prescription-drug-and-biological.
  • Leiknes KA, Cooke MJ, Jarosch-von Schweder L, et al. Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health. 2015;18:1–39.
  • Ward HB, Fromson JA, Cooper JJ, et al. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol.[erratum appears in arch womens ment health. 2018 Jun 23; PMID: 29934883]. Arch Womens Ment Health. 2018;21:715–722.
  • Cohen RB, Ferreira MS, Ferreira MJL, et al. Use of repetitive transcranial magnetic stimulation for the management of bipolar disorder during the postpartum period. Brain Stimul. 2008;1:224–226.
  • Xiong W, Lopez R, Cristancho P. Transcranial magnetic stimulation in the treatment of peripartum bipolar depression: A case report. Rev Bras Psiquiatr. 2018;40:344–345.
  • Sharma V, Singh P, Baczynski C, et al. A closer look at the nosological status of the highs (hypomanic symptoms) in the postpartum period. Arch Womens Ment Health. 2020. DOI:10.1007/s00737-020-01023-1.
  • Wang -Y-Y, Li X, Duan Z, et al. Screening for postpartum hypomania among Chinese women after childbirth. Psychiatry Res. 2019;282:112591.
  • Glover V, Liddle P, Taylor A, et al. Mild hypomania (the highs) can be a feature of the first postpartum week. Association with later depression. Br J Psychiatry. 1994;164:517–521.
  • Lane A, Keville R, Morris M, et al. Postnatal depression and elation among mothers and their partners: prevalence and predictors. Br J Psychiatry. 1997;171:550–555.
  • Hasegawa M. Mild hypomania phenomenon in Japanese puerperal women. Nurs Heal Sci. 2000;2:231–235.
  • Webster J, Pritchard MA, Creedy D, et al. A simplified predictive index for the detection of women at risk for postnatal depression. Birth. 2003;30:101–108.
  • Heron J, Haque S, Oyebode F, et al. A longitudinal study of hypomania and depression symptoms in pregnancy and the postpartum period. Bipolar Disord. 2009;11:410–417.
  • Smith S, Heron J, Haque S, et al. Measuring hypomania in the postpartum: a comparison of the highs scale and the altman mania rating scale. Arch Womens Ment Health. 2009;12:323–327.
  • Pingo J, van den Heuvel LL, Vythylingum B, et al. Probable postpartum hypomania and depression in a South African cohort. Arch Womens Ment Health. 2017;20:427–437.
  • Sharma V, Xie B, Campbell MK, et al. A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum. Bipolar Disord. 2014;16:16–21.
  • Inglis AJ, Hippman CL, Carrion PB, et al. Mania and depression in the perinatal period among women with a history of major depressive disorders. Arch Womens Ment Health. 2014;17:137–143.
  • Azorin J-M, Angst J, Gamma A, et al. Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. J Affect Disord. 2012;136:710–715.
  • Munk-Olsen T, Laursen TM, Meltzer-brody S, et al. Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry. 2012;69:428–434.
  • Sharma V. A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord. 2006;8:411–414.
  • Çelik SB, Bucaktepe GE, Uludağ A, et al. Screening mixed depression and bipolarity in the postpartum period at a primary health care center. Compr Psychiatry. 2016;71:57–62.
  • Koukopoulos AE, Angeletti G, Sani G, et al. Perinatal mixed affective state: wherefore art thou?. Psychiatr Clin North Am. 2020;43:113–126.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.
  • Sharma V, Xie B. Screening for postpartum bipolar disorder: validation of the mood disorder questionnaire. J Affect Disord. 2011;131:408–411.
  • Sharma V. Relationship of bipolar disorder with psychiatric comorbidity in the postpartum period — a scoping review. Arch Womens Ment Heal. 2018;21:141–147.
  • Sharma V, Smith A, Mazmanian D. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disord. 2006;8:400–404.
  • Wisner KL, Hanusa BH, Peindl KS, et al. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry. 2004;56:592–596.
  • Wesseloo R, Kamperman AM, Munk-Olsen T, et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173:117–127.
  • Sharma V, Bergink V, Berk M, et al. Childbirth and prevention of bipolar disorder: an opportunity for change. Lancet Psychiatry. 2019;6:786–792.
  • Sharma V, Khan M, Sommerdyk C. Quetiapine in the acute treatment of bipolar postpartum depression: a chart review. J Clin Psychopharmacol. 2015;35:733–735.
  • Misri S, Abizadeh J, B. Eng A, et al. an open-label study of quetiapine extended-release in a sample of postpartum women with bipolar II depressive episode. Curr Psychopharmacol. 2015;4:17–26.
  • Rybakowski J, Jerzy CW, Ałeck PG, et al. Recommendations of the polish psychiatric association regarding the treatment of affective disorders in women of childbearing age. Part II: bipolar disorder. Psychiatr Pol. 2019;53:263–276.
  • Jones I, Smith S. Puerperal psychosis: identifying and caring for women at risk. Adv Psychiatr Treat. 2009;15:411–418.
  • VanderKruik R, Barreix M, Chou D, et al. The global prevalence of postpartum psychosis: a systematic review. BMC Psychiatry. 2017;17:272.
  • Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry. 2001;158:913–917.
  • Sharma V, Mazmanian D. Sleep loss and postpartum psychosis. Bipolar Disord. 2003;5:98–105.
  • Lewis KJS, Foster RG, Jones IR. Is sleep disruption a trigger for postpartum psychosis?. Br J Psychiatry. 2016;208:409–411.
  • Blackmore ER, Jones I, Doshi M, et al. Obstetric variables associated with bipolar affective puerperal psychosis. Br J Psychiatry. 2006;188:32–36.
  • Sharma V, Sommerdyk C. Postpartum psychosis: what is in a name?. Aust New Zeal J Psychiatry. 2014;48:1081–1082.
  • Kamperman AM, Veldman-Hoek MJ, Wesseloo R, et al. Phenotypical characteristics of postpartum psychosis: A clinical cohort study. Bipolar Disord. 2017;19:450–457.
  • Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. BJOG An Int J Obstet Gynaecol. 2011;118:1–203.
  • Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry. 2009;166:405–408.
  • Osborne LM. Recognizing and managing postpartum psychosis: a clinical guide for obstetric providers. Obstet Gynecol Clin North Am. 2018;45:455–468.
  • Bergink V, Burgerhout KM, Koorengevel KM, et al. Treatment of psychosis and mania in the postpartum period. Am J Psychiatry. 2015;172:115–123.
  • Rönnqvist I, Brus O, Hammar Å, et al. Rehospitalization of postpartum depression and psychosis after electroconvulsive therapy. J Ect. 2019;35:264–271.
  • Uguz F, Sharma V. Mood stabilizers during breastfeeding: a systematic review of the recent literature. Bipolar Disord. 2016;18:325–333.
  • Uguz F. Second-generation antipsychotics during the lactation period a comparative systematic review on infant safety. J Clin Psychopharmacol. 2016;36:244–252.
  • Pacchiarotti I, León-Caballero J, Murru A, et al. Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder. Eur Neuropsychopharmacol. 2016;26:1562–1578.
  • Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007;164:342–345.
  • Rasmussen MLH, Strøm M, Wohlfahrt J, et al. Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study. PLoS Med. 2017;14:e1002392.
  • Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1–44.
  • Grof P, Robbins W, Alda M, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord. 2000;61:31–39.
  • Pariente G, Leibson T, Shulman T, et al. Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs. 2017;31:439–450.
  • Coughlin CG, Blackwell KA, Bartley C, et al. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015;125:1224–1235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.